Pathogenic Microbial Testing Project
Subdivision categories | Entry name | Methodology | Detection significance |
Hepatitis B | Quantitative detection of Hepatitis B virus (HBV) nucleic acid | Fluorescence PCR method | Reflect the content of Hepatitis B virus and the active degree of virus replication in human body |
Hepatitis B | High sensitivity quantitative detection of Hepatitis B virus (HBV) nucleic acid | Fluorescence PCR method | More accurate detection of low concentration of Hepatitis B virus provides a basis for clinical diagnosis, prognosis and treatment effect evaluation. |
Hepatitis B | Hepatitis B virus (HBV) genotyping detection | Fluorescence PCR method | Determine the course, outcome, and pathogenicity of the virus, and guide the selection of treatment plans. |
Hepatitis B | Detection of YMDD gene mutations in Hepatitis B virus (HBV) | Fluorescence PCR method | Provide basis for the use of Lamivudine |
Hepatitis B | Detection of Hepatitis B Virus (HBV) Resistance Genetic testing | Fluorescence PCR method | Timely adjustment of treatment plans, rational medication, and improvement of treatment effectiveness. |
Hepatitis C | Quantitative detection of hepatitis C virus (HCV) nucleic acid | Fluorescence PCR method | As an indicator for evaluating the efficacy of antiviral therapy, it guides the evaluation of antiviral therapy and efficacy. |
Hepatitis C | High sensitivity quantitative detection of hepatitis C virus (HCV) nucleic acid | Fluorescence PCR method | More accurate detection of low concentrations of hepatitis C virus provides a basis for evaluating disease activity, assessing efficacy, and optimizing antiviral treatment. |
Hepatitis C | Genotyping detection of hepatitis C virus (HCV) | Fluorescence PCR method | It helps to determine the difficulty of treatment and develop individual plans for antiviral treatment. |
Sexually transmitted diseases | Human papillomavirus (HPV) 6/11 Nucleic acid test | Fluorescence PCR method | Assistant diagnosis of Genital wart |
Sexually transmitted diseases | Human papillomavirus (HPV) 16/18 Nucleic acid test | Fluorescence PCR method | It has high guiding significance in the early diagnosis of cervical cancer |
Sexually transmitted diseases | Human papillomavirus (HPV) 28 typing Nucleic acid test | Fluorescence PCR method | Identifying virus subtypes is of great value for prognosis, diagnosis, and formulation of treatment measures. |
Sexually transmitted diseases | Chlamydia trachomatis (CT) Nucleic acid test | Fluorescence PCR method | Assisted diagnosis of Chlamydia trachomatis infection |
Sexually transmitted diseases | Neisseria gonorrhoeae (NG) Nucleic acid test | Fluorescence PCR method | Auxiliary diagnosis of Neisseria gonorrhoeae infection |
Sexually transmitted diseases | Ureaplasma urealyticum (UU) Nucleic acid test | Fluorescence PCR method | Assisted diagnosis of ureaplasma urealyticum infection |
Sexually transmitted diseases | Herpes simplex virus (HSV) I/II typing Nucleic acid test | Fluorescence PCR method | Auxiliary diagnosis of Herpes simplex virus infection |
Sexually transmitted diseases | Mycoplasma genitalium (MG) Nucleic acid test | Fluorescence PCR method | Assisting in the diagnosis of Mycoplasma infection |
Sexually transmitted diseases | Mycoplasma hominis (MH) Nucleic acid test | Fluorescence PCR method | Assisting in the diagnosis of infection with Mycoplasma hominis |
Tuberculosis | RpoB gene and mutation detection of Xpert Mycobacterium Tuberculosis | Fluorescence PCR method | It is used for rapid diagnosis of Tuberculosis infection to determine whether there is Rifampicin resistance. |
Tuberculosis | Detection of Fluoroquinolones Resistance Mutation Genetic testing in Mycobacterium Tuberculosis | Fluorescence PCR method | Provide reference for the use of fluoroquinolones |
Tuberculosis | Detection of Rifampicin resistant mutant Genetic testing in Mycobacterium Tuberculosis | Fluorescence PCR method | Provide reference for the use of Rifampicin |
Tuberculosis | Detection of Streptomycin resistant mutant Genetic testing in Mycobacterium Tuberculosis | Fluorescence PCR method | Provide reference for the use of Streptomycin |
Tuberculosis | Detection of Isoniazid resistant mutant Genetic testing of Mycobacterium Tuberculosis | Fluorescence PCR method | Provide reference for the use of Isoniazid |
Tuberculosis | Detection of Ethambutol resistant mutant Genetic testing in Mycobacterium Tuberculosis | Fluorescence PCR method | Provide reference for the use of Ethambutol |
Tuberculosis | Nucleic acid test of Mycobacterium Tuberculosis (TB) | Fluorescence PCR method | Assisting in the diagnosis of Mycobacterium Tuberculosis infection |
enterovirus | Xpert Nucleic acid test of Clostridium difficile | Fluorescence PCR method | Assisting in the diagnosis of Clostridium difficile infection |
enterovirus | Norovirus (NV) Nucleic acid test | Fluorescence PCR method | Auxiliary diagnosis of Norovirus infection |
enterovirus | Detection of methicillin-resistant gene MecA in Methicillin-resistant Staphylococcus aureus | Fluorescence PCR method | Assist in diagnosis of Staphylococcus aureus infection and guide the use of Methicillin. |
enterovirus | Enterovirus universal (EV) Nucleic acid test | Fluorescence PCR method | Assisted diagnosis of hand, foot, and mouth disease |
enterovirus | Enterovirus 71 (EV71) Nucleic acid test | Fluorescence PCR method | Assisted diagnosis of hand, foot, and mouth disease |
enterovirus | Nucleic acid test of Coxsackie virus A61 (CA61) | Fluorescence PCR method | Assisted diagnosis of hand, foot, and mouth disease |
enterovirus | Nucleic acid test of Coxsackie virus A16 (CA16) | Fluorescence PCR method | Assisted diagnosis of hand, foot, and mouth disease |
Respiratory virus | Novel coronavirus (2019 nCoV) Nucleic acid test | Fluorescence PCR method | Auxiliary diagnosis of novel coronavirus (2019 nCoV) infection |
Respiratory virus | Detection of Coronavirus 229E Nucleic acid test | Fluorescence PCR method | Assisted diagnosis of coronavirus 229E infection |
Respiratory virus | Detection of Coronavirus OC43 Nucleic acid test | Fluorescence PCR method | Assisted diagnosis of COVID-19 OC43 infection |
Respiratory virus | Detection of coronavirus NL63 Nucleic acid test | Fluorescence PCR method | Assisted diagnosis of coronavirus NL63 infection |
Respiratory virus | Detection of coronavirus HKU1 Nucleic acid test | Fluorescence PCR method | Assisted diagnosis of coronavirus HKU1 infection |
Respiratory virus | Nucleic acid test of influenza A and Influenza B virus | Fluorescence PCR method | Auxiliary diagnosis of influenza A and Influenza B virus infection |
Respiratory virus | Nucleic acid test of Influenza A virus | Fluorescence PCR method | Auxiliary diagnosis of Influenza A virus infection |
Respiratory virus | Influenza B virus Nucleic acid test | Fluorescence PCR method | Auxiliary diagnosis of Influenza B virus infection |
Respiratory virus | Nucleic acid test of influenza A (H1N1) virus (2009) | Fluorescence PCR method | Assisting in the diagnosis of influenza A (H1N1) virus infection (2009) |
Respiratory virus | Parainfluenza virus Nucleic acid test | Fluorescence PCR method | Assisting in the diagnosis of parainfluenza virus infection |
Respiratory virus | Rubella virus (RV) Nucleic acid test | Fluorescence PCR method | Assisting in the diagnosis of rubella virus infection |
Respiratory virus | Nucleic acid test of Bordetella pertussis (BP) | Fluorescence PCR method | Assisted diagnosis of pertussis |
Respiratory virus | Bocaparvovirus Nucleic acid test | Fluorescence PCR method | Auxiliary diagnosis of Bocaparvovirus infection |
Respiratory virus | Adenovirus Nucleic acid test | Fluorescence PCR method | Auxiliary diagnosis of Adenovirus infection |
Respiratory virus | Respiratory syncytial virus (RSV) Nucleic acid test | Fluorescence PCR method | Assisted diagnosis of respiratory syncytial virus infection |
Respiratory virus | Nucleic acid test of chlamydia pneumoniae (CP) and mycoplasma (MP) | Fluorescence PCR method | Assisting in the diagnosis of chlamydia and mycoplasma infections |
Respiratory virus | Detection of nucleic acid and drug-resistant mutation sites of Mycoplasma pneumoniae | Fluorescence PCR method | Assisting in the diagnosis of Mycoplasma infection and providing reference for the use of therapeutic drugs. |
Respiratory virus | Rhinovirus (RHV) Nucleic acid test | Fluorescence PCR method | Auxiliary diagnosis of Rhinovirus infection |
Respiratory virus | Nucleic acid test of Klebsiella pneumoniae (KP) | Fluorescence PCR method | Assisted diagnosis of Klebsiella pneumoniae infection |
Respiratory virus | Legionella pneumophila (LP) Nucleic acid test | Fluorescence PCR method | Auxiliary diagnosis of Legionella pneumophila infection |
Brain Tumors | Quantitative detection of JCV nucleic acid | Fluorescence PCR method | Assisted diagnosis of JC virus infection |
Nasopharyngeal C | Quantitative detection of EB virus nucleic acid | Fluorescence PCR method | Assisting in the diagnosis of EB virus infection |
Nephropathy | Quantitative detection of BK virus (BKV) nucleic acid | Fluorescence PCR method | Assisting in the diagnosis of BK virus infection |
Maternal and Child Health | Quantitative detection of cytomegalovirus (CMV) nucleic acid | Fluorescence PCR method | Assisted diagnosis of cytomegalovirus infection |
Maternal and Child Health | Toxoplasma gondii (TOX) Nucleic acid test | Fluorescence PCR method | Auxiliary diagnosis of Toxoplasma gondii infection |
Maternal and Child Health | Group B streptococcus (GBS) Nucleic acid test | Fluorescence PCR method | Assisting in Diagnosis of Group B Streptococcus Infection |
Helicobacter pylori | Detection of 23S rRNA gene and gyrA gene mutations in Helicobacter pylori | Fluorescence PCR method | It is used for the auxiliary diagnosis of Clarithromycin resistance and quinolone resistance of Helicobacter pylori, and provides reference for clinicians to evaluate the drug resistance of Helicobacter pylori in individuals. |
Microbial identification | Nanoseq pathogen (DNA, RNA) metagenomic detection | Third-generation sequencing method | Accurately diagnose the pathogens infected by patients and provide reference basis for timely and accurate medication |
Microbial identification | Multiple targeted detection of pathogenic microorganisms | Third-generation sequencing method | Detect 188 pathogenic microorganisms and 9 common resistance genes, helping clinical rapid identification of pathogenic bacteria and precise use of antibiotics. |
keyword:
Category:
Molecular Diagnostics